These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27300318)

  • 1. The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.
    Samaraweera AP; Clarke MA; Whitehead A; Falah Y; Driver ID; Dineen RA; Morgan PS; Evangelou N
    J Neuroimaging; 2017 Jan; 27(1):114-121. PubMed ID: 27300318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?
    Campion T; Smith RJP; Altmann DR; Brito GC; Turner BP; Evanson J; George IC; Sati P; Reich DS; Miquel ME; Schmierer K
    Eur Radiol; 2017 Oct; 27(10):4257-4263. PubMed ID: 28409356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: High prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images.
    Sparacia G; Agnello F; Gambino A; Sciortino M; Midiri M
    Neuroradiol J; 2018 Aug; 31(4):356-361. PubMed ID: 29565219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.
    Mistry N; Abdel-Fahim R; Samaraweera A; Mougin O; Tallantyre E; Tench C; Jaspan T; Morris P; Morgan PS; Evangelou N
    Mult Scler; 2016 Sep; 22(10):1289-96. PubMed ID: 26658816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWAN-Venule: An Optimized MRI Technique to Detect the Central Vein Sign in MS Plaques.
    Gaitán MI; Yañez P; Paday Formenti ME; Calandri I; Figueiredo E; Sati P; Correale J
    AJNR Am J Neuroradiol; 2020 Mar; 41(3):456-460. PubMed ID: 32054616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD.
    Samaraweera APR; Falah Y; Pitiot A; Dineen RA; Morgan PS; Evangelou N
    Neurol Neuroimmunol Neuroinflamm; 2018 Nov; 5(6):e496. PubMed ID: 30345329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
    Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
    JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty.
    Clarke MA; Samaraweera AP; Falah Y; Pitiot A; Allen CM; Dineen RA; Tench CR; Morgan PS; Evangelou N
    Mult Scler; 2020 Apr; 26(4):433-441. PubMed ID: 31668125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central vein sign is present in most infratentorial multiple sclerosis plaques.
    Gaitán MI; Paday Formenti ME; Calandri I; Ysrraelit MC; Yañez P; Correale J
    Mult Scler Relat Disord; 2022 Feb; 58():103484. PubMed ID: 35007822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?
    Lummel N; Boeckh-Behrens T; Schoepf V; Burke M; Brückmann H; Linn J
    Neuroradiology; 2011 May; 53(5):311-7. PubMed ID: 20585764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing multiple sclerosis misdiagnosis using the "central vein sign": A real-world study.
    Kaisey M; Solomon AJ; Guerrero BL; Renner B; Fan Z; Ayala N; Luu M; Diniz MA; Sati P; Sicotte NL
    Mult Scler Relat Disord; 2021 Feb; 48():102671. PubMed ID: 33444958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis.
    Daboul L; O'Donnell CM; Cao Q; Amin M; Rodrigues P; Derbyshire J; Azevedo C; Bar-Or A; Caverzasi E; Calabresi P; Cree BAC; Freeman L; Henry RG; Longbrake EE; Nakamura K; Oh J; Papinutto N; Pelletier D; Samudralwar RD; Suthiphosuwan S; Schindler MK; Sotirchos ES; Sicotte NL; Solomon AJ; Shinohara RT; Reich DS; Ontaneda D; Sati P
    AJR Am J Roentgenol; 2023 Jan; 220(1):115-125. PubMed ID: 35975888
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis.
    Lamot U; Avsenik J; Šega S; Šurlan Popovič K
    Mult Scler Relat Disord; 2017 Apr; 13():67-72. PubMed ID: 28427705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
    Kau T; Taschwer M; Deutschmann H; Schönfelder M; Weber JR; Hausegger KA
    Eur Radiol; 2013 Jul; 23(7):1956-62. PubMed ID: 23436147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter Lesions.
    Dworkin JD; Sati P; Solomon A; Pham DL; Watts R; Martin ML; Ontaneda D; Schindler MK; Reich DS; Shinohara RT
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1806-1813. PubMed ID: 30213803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions.
    Tallantyre EC; Morgan PS; Dixon JE; Al-Radaideh A; Brookes MJ; Evangelou N; Morris PG
    Invest Radiol; 2009 Sep; 44(9):491-4. PubMed ID: 19652606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis: A 3-Year Longitudinal Study.
    Al-Louzi O; Letchuman V; Manukyan S; Beck ES; Roy S; Ohayon J; Pham DL; Cortese I; Sati P; Reich DS
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35027474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central vein sign in multiple sclerosis patients with vascular comorbidities.
    Guisset F; Lolli V; Bugli C; Perrotta G; Absil J; Dachy B; Pot C; Théaudin M; Pasi M; van Pesch V; Maggi P
    Mult Scler; 2021 Jun; 27(7):1057-1065. PubMed ID: 32749948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CVSnet: A machine learning approach for automated central vein sign assessment in multiple sclerosis.
    Maggi P; Fartaria MJ; Jorge J; La Rosa F; Absinta M; Sati P; Meuli R; Du Pasquier R; Reich DS; Cuadra MB; Granziera C; Richiardi J; Kober T
    NMR Biomed; 2020 May; 33(5):e4283. PubMed ID: 32125737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.